Insulin pump for young athletes with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests how well the Tandem Mobi insulin pump and Dexcom continuous glucose monitor work for young competitive athletes with type 1 diabetes. If you join, you'll use this system during your regular training and competition to see how safe and easy it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 11 and 18 years old.
- You must have had type 1 diabetes for at least 6 months.
- You must already be using an insulin pump or an automated insulin delivery system.
- You must be willing to switch to the Tandem Mobi pump system and a Dexcom continuous glucose monitor for the study.
- You must be a competitive athlete (someone who trains and competes in a sport).
- You cannot have had two or more severe low blood sugar episodes in the last 6 months, nor any hospitalization for diabetic ketoacidosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This study tests whether starting an automated insulin delivery (AID) system soon after a type 1 diabetes diagnosis helps improve blood sugar control and reduces future health problems. The AID system combines a pump and continuous glucose monitor to automatically adjust insulin.
This study observes how well the Control-IQ insulin pump system works for teenagers with type 1 diabetes who exercise at least twice a week. It aims to see if the technology is safe and effective during regular physical activity.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.